Re:Mylan’s EpiPen price hike was a scheme to stifle competit...
by maxerickson on Wednesday April 26, 2017 @10:00AM
(#14202979)
EpiPen prices occur in a heavily regulated market. Mylan has a patent on the mechanism they sell (no generics from other companies) and there are all sorts of regulations surrounding the production of any drug offered for sale in the US.
[ Parent
| on HN ]
There are no comments on this comment yet.